Pharmacy Market BUZZ

Market News, Products, Services, and Trends


Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. News & Announcements

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.

press release

April 8, 2024 | Press Releases

Bayer and Dr. Reddy’s sign a marketing and distribution agreement for second brand of Vericiguat™ in India

Posted by RXinsider Staff RXinsider Staff


press release

April 3, 2024 | Press Releases

Aurigene Pharmaceutical Services Ltd. introduces Aurigene.AI™, an artificial intelligence (AI) and machine learning (ML) assisted drug discovery platform

Posted by RXinsider Staff RXinsider Staff


press release

March 28, 2024 | Press Releases

Dr. Reddy's enters into exclusive distribution partnership with Sanofi Healthcare India Private Limited for their vaccine brands in India

Posted by RXinsider Staff RXinsider Staff


DrReddys

March 27, 2024 | Product Awareness

Dr. Reddy's | Count on generics. Now more than ever.

Posted by RXinsider Staff RXinsider Staff


press release

March 20, 2024 | Product Awareness

Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK

Posted by RXinsider Staff RXinsider Staff


pharmaceutical

March 1, 2024 | Product Awareness

March Market Leaders: Pharmaceutical Manufacturers

Posted by RXinsider Staff RXinsider Staff


Spotlights by RXinsider

February 12, 2024 | SPOTLIGHTS

Dr. Reddy’s Redefining Medicine Accessibility With Generics

Posted by Martha Jones Martha Jones


press release

January 3, 2024 | Press Releases

Dr. Reddy's announces the acquisition of MenoLabs® , a leading women’s health and dietary supplements portfolio of brands

Posted by RXinsider Staff RXinsider Staff


press release

December 14, 2023 | Product Awareness

Dr. Reddy’s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index

Posted by RXinsider Staff RXinsider Staff


press release

December 11, 2023 | Press Releases

Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Posted by RXinsider Staff RXinsider Staff


DrReddy's

December 11, 2023 | Product Awareness

Dr.Reddy’s | Count On Generics. Now More Than Ever. [VIDEO]

Posted by RXinsider Staff RXinsider Staff


press release

August 16, 2023 | Press Releases

Dr. Reddy's Laboratories announces its launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S.

Posted by RXinsider Staff RXinsider Staff


Dr. Reddy's

August 10, 2023 | Product Awareness

Your Virtual Store at Your Fingertips | Dr.Reddy’s

Posted by RXinsider Staff RXinsider Staff


press release

August 9, 2023 | Press Releases

Dr. Reddy’s proposed rituximab biosimilar application accepted for review by USFDA, EMA and MHRA

Posted by RXinsider Staff RXinsider Staff


Dr. Reddy's

August 4, 2023 | Product Awareness

Your Virtual Store at Your Fingertips | Dr.Reddy’s [VIDEO]

Posted by RXinsider Staff RXinsider Staff


press release

August 3, 2023 | Press Releases

Dr. Reddy’s successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumab

Posted by RXinsider Staff RXinsider Staff


must see mkcesson ideashare

June 23, 2023 | Must-See Exhibits & Booths

Must See Booths: McKesson ideaShare 2023

Posted by RXinsider Staff RXinsider Staff


press release

May 24, 2023 | Press Releases

Aurigene Pharmaceutical Services to expand biologics CDMO capacity with a new biomanufacturing facility

Posted by RXinsider Staff RXinsider Staff


press release

April 27, 2023 | Press Releases

Dr. Reddy's Laboratories announces the launch of Treprostinil Injection in the U.S.

Posted by RXinsider Staff RXinsider Staff


dr.reddy's

April 21, 2023 | Product Awareness

Dr.Reddy’s | Your Virtual Store at Your Fingertips [VIDEO]

Posted by RXinsider Staff RXinsider Staff


dr.reddy's

March 17, 2023 | Product Awareness

Dr.Reddy’s | Your Virtual Store at Your Fingertips

Posted by RXinsider Staff RXinsider Staff


press release

March 2, 2023 | Press Releases

Dr. Reddy's Laboratories Announces Agreement to Acquire Mayne Pharma’s U.S. Generic Prescription Product Portfolio

Posted by RXinsider Staff RXinsider Staff


March Ecosystem cleanrooms

March 1, 2023 | Product Awareness

March Market Leaders: Pharmaceutical Manufacturers

Posted by RXinsider Staff RXinsider Staff


Spotlights by RXinsider

March 1, 2023 | SPOTLIGHTS

Bringing Science, Technology, and Innovation Together

Posted by Martha Jones Martha Jones


press release

February 3, 2023 | Press Releases

Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


must see ashp 2022

December 2, 2022 | Must-See Exhibits & Booths

Must See Booths: ASHP Midyear Clinical Meeting & Exhibition 2022

Posted by RXinsider Staff RXinsider Staff


press release

October 12, 2022 | Press Releases

World Economic Forum recognises Dr. Reddy’s Hyderabad factory as part of its Global Lighthouse Network

Posted by RXinsider Staff RXinsider Staff


September 27, 2022 | Press Releases

Dr. Reddy's Laboratories announces the launch of Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-market, 180-day exclusivity

Posted by RXinsider Staff RXinsider Staff


NACDS TSE must see

August 27, 2022 | Must-See Exhibits & Booths

Must See Booths: NACDS Total Store Expo 2022

Posted by RXinsider Staff RXinsider Staff


press release

August 18, 2022 | Press Releases

Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


August 15, 2022 | Product Awareness

Dr. Reddy’s | Your Virtual Store at Your Fingertips [VIDEO]

Posted by RXinsider Staff RXinsider Staff


press release

August 8, 2022 | Press Releases

Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


July 21, 2022 | Product Awareness

Dr. Reddy's Salutes Your Selfless Dedication, Rigorous Attention to Detail, and Commitment to Patients Everywhere. [VIDEO]

Posted by RXinsider Staff RXinsider Staff


July 11, 2022 | Product Awareness

Dr. Reddy’s | Your Virtual Store at Your Fingertips

Posted by RXinsider Staff RXinsider Staff


May 2, 2022 | Must-See Exhibits & Booths

Must See Booths: Asembia Summit 2022

Posted by RXinsider Staff RXinsider Staff


press release

April 13, 2022 | Press Releases

Dr. Reddy's Laboratories announces the launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


March 10, 2022 | Product Awareness

Dr. Reddy's Salutes Your Selfless Dedication, Rigorous Attention to Detail, and Commitment to Patients Everywhere.

Posted by RXinsider Staff RXinsider Staff


march ecosystem

March 1, 2022 | Product Awareness

March Market Leaders: Pharmaceutical Manufacturers

Posted by RXinsider Staff RXinsider Staff


press release

February 18, 2022 | Press Releases

Dr. Reddy's Laboratories announces the launch of its authorized generic version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

February 2, 2022 | Press Releases

Akhil Ravi appointed CEO of Aurigene Pharmaceutical Services Ltd.

Posted by RXinsider Staff RXinsider Staff


press release

November 19, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

November 15, 2021 | Press Releases

Dr. Reddy's Laboratories announces approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)

Posted by RXinsider Staff RXinsider Staff


press release

November 9, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Carmustine for Injection, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


asembia must see

October 25, 2021 | Must-See Exhibits & Booths

Must See Booths: Asembia Specialty Summit 2021 - Dr. Reddy's Laboratories

Posted by RXinsider Staff RXinsider Staff


press release

September 3, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr reddy

August 6, 2021 | Product Awareness

You make Promises. We help you keep them.

Posted by RXinsider Staff RXinsider Staff


Dr reddy

July 1, 2021 | Product Awareness

You make Promises. We help you keep them.

Posted by RXinsider Staff RXinsider Staff


press release

June 30, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Icosapent Ethyl Capsules, 1 gram in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr. Reddy's

May 17, 2021 | Product Awareness

You make Promises. We help you keep them. [VIDEO]

Posted by RXinsider Staff RXinsider Staff


May 14, 2021 | Product Awareness

Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

April 7, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of a generic version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


march ecosystem

March 1, 2021 | Product Awareness

March Market Leaders: Pharmaceutical Manufacturers

Posted by RXinsider Staff RXinsider Staff


February 22, 2021 | Product Awareness

Dr. Reddy's Laboratories announces the launch of Capecitabine Tablets, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

February 18, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Vigabatrin Tablets, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr reddy

January 8, 2021 | Product Awareness

You make Promises. We help you keep them.

Posted by RXinsider Staff RXinsider Staff


press release

December 23, 2020 | Press Releases

Dr. Reddy's Laboratories, Global Response Aid, and Appili Therapeutics announce the filing of an application for REEQONUS™ (favipiravir) Tablets for the treatment of COVID-19 under Health Canada’s Interim Order

Posted by RXinsider Staff RXinsider Staff


October 12, 2020 | Product Awareness

Dr. Reddy's Laboratories announces the launch of Cinacalcet Tablets in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


October 9, 2020 | Product Awareness

Dr. Reddy's announces the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


October 5, 2020 | Product Awareness

Dr. Reddy's Laboratories announces the launch of Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

September 28, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

September 23, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

September 18, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Spotlights by RXinsider

September 11, 2020 | SPOTLIGHTS

Injectable Medicines Through World-Class Capabilities - Dr. Reddy's Laboratories

Posted by Martha Jones Martha Jones


press release

September 10, 2020 | Press Releases

Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

September 3, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr. Reddy's

July 29, 2020 | Product Awareness

We are Committed to Making Affordable and Innovative Injectable Medicines - Dr. Reddy's [VIDEO]

Posted by RXinsider Staff RXinsider Staff


press release

June 19, 2020 | Press Releases

Dr. Reddy’s Laboratories Completes the Acquisition of Select Business Divisions of Wockhardt

Posted by RXinsider Staff RXinsider Staff


press release

June 17, 2020 | Press Releases

Dr. Reddy's Laboratories Announces the Launch of Colchicine Tablets USP, 0.6 mg in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr. Reddys

May 29, 2020 | Product Awareness

We are Committed to Making Affordable and Innovative Injectable Medicines - Dr. Reddy's

Posted by RXinsider Staff RXinsider Staff


press release

May 12, 2020 | Press Releases

Dr. Reddy's Laboratories received approval for their NDA, ELYXYB™ (celecoxib oral solution) 25 mg/mL, in the U.S.

Posted by RXinsider Staff RXinsider Staff


press release

May 8, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


march ecosystem

March 20, 2020 | Product Awareness

March Market Leaders: Pharmaceutical Manufacturers

Posted by RXinsider Staff RXinsider Staff


press release

March 20, 2020 | Press Releases

Dr. Reddy's Launches 1st Generic of Geodon for Injection

Posted by RXinsider Staff RXinsider Staff

LOAD MORE
Today's Posts